NOGA Therapeutics

We're happy to share that on March 11th at 12 PM EST, we're hosting a webinar featuring our Co-Founder and CEO, Noam Baumatz, who will share his personal story that inspired him to launch NOGA Therapeutics. This is a unique opportunity to learn how personal experiences can drive scientific breakthroughs and advance gene therapy for rare diseases. We hope to see you there! 🔗 Link to RSVP is in the comments.

Last week we had an inspiring and thought-provoking discussion with Professor Steffen Jung at the Weizmann Institute of Science, diving deep into anti-inflammatory mechanisms and how they intersect with our approach to chronic conditions like Inflammatory Bowel Disease (IBD) and Parkinson’s disease. At Noga Therapeutics, we believe that engineered macrophages hold the key to restoring immune balance in chronic diseases. Our platform harnesses HSC-derived macrophages to deliver targeted, sustained therapeutic effects, addressing both inflammation and disease progression. Key takeaways from our meeting:  *The critical role of macrophages in modulating inflammation across multiple tissues.  *How tissue-specific immune regulation can shape better therapeutic outcomes.  *Potential applications of our HSC-based gene therapy in addressing both neurodegenerative and autoimmune diseases. *IBD and Parkinson’s, despite their differences, share common inflammatory pathways—a deeper understanding of these mechanisms helps us refine our macrophage-driven approach to provide lifelong, single-treatment solutions. Excited to continue translating these insights into action! A huge thank you to Prof. Jung and his team for their invaluable expertise. #GeneTherapy #Inflammation #Neuroscience #IBD #Parkinsons #BiotechInnovation #WeizmannInstitute

Today marks six years since the passing of Noga, the beloved daughter of our founder & CEO, Noam Baumatz. Noga’s story is the heart of our mission at Noga Therapeutics. Her memory fuels Noam's unwavering dedication to treating and curing rare diseases and supporting families navigating these challenging diseases. Our work is a testament to her legacy, as we strive to bring hope and healing to those affected by rare diseases. We honor Noga today and every day, as we continue our commitment to making a difference in the lives of families around the world.

We're so pleased to see that Michael J. Fox was awarded the Presidential Medal of Freedom -- a truly well deserved honor. We're deeply grateful for the strides The Michael J. Fox Foundation for Parkinson's Research has made in advancing understanding and treatment options for this complex disease. Thank you for being a beacon of hope and a relentless advocate for the Parkinson's community. We're proud to stand alongside you in this journey toward a brighter future.

This week, our founder and CEO Noam Baumatz was featured on the Renegade Science podcast with Maria Nimfuehr. In this episode, Noam dives deep into the world of gene therapy, exploring how our innovative platform is shaping the future of treatments for rare genetic diseases and beyond. Listen to (or watch!) the episode to learn more about Noga Therapeutics -- link in comments.

Our founder and CEO, Noam Baumatz was featured on rarecast, Global Genes podcast this week. Listen to learn more about the work that Noam and our team at Noga Therapeutics are doing.

Noga Therapeutics founder & CEO, Noam Baumatz spoke with Patrick Short on The Genetics Podcast by Sano Genetics. Listen in to hear Patrick and Noam discuss: 🧬 How Noam’s personal experience with rare disease inspired him to take gene therapy development into his own hands 🩸 Working with macrophages to develop new gene therapies for primary immune deficiencies 💊 Bridging the gap between developing transformative therapies and delivering financially accessible drugs to small ultra-rare disease populations Link to listen in the comments.